Pre-operative Spirometry in a Patient with New Chest Pain and Irregular Tachycardia

Do not test now. The decision is driven by three findings acting together, not by any single number:

• Chest pressure at rest within 24 hours - this is an acute coronary syndrome until proven otherwise. It is not merely a relative contraindication to spirometry; it is an indication for immediate medical evaluation. The forced maneuvers raise intrathoracic pressure, reduce venous return, and increase myocardial oxygen demand.
• New irregularly irregular tachycardia at 118/min with BP 172/98 - this is "unstable cardiovascular status," which the laboratory's own policy already lists as a contraindication. A rate of 118 at rest also breaches the usual exclusion thresholds (resting tachycardia generally >120/min, systolic >200 mmHg, diastolic >120 mmHg) as a warning zone.
• Resting SpO2 94% with a 45-pack-year history - the patient has limited reserve for a maneuver that can provoke desaturation and syncope.

Actions in the next 15 minutes:

1. Do not perform spirometry. Do not send him home alone.
2. Escalate to the physician covering the laboratory (or the surgeon's office) with the vitals and symptom description, and arrange same-day ECG/urgent evaluation - not "next week."
3. Document: the symptoms verbatim, the vitals, the time the physician was contacted, the name of the person who gave the instruction, and the fact that testing was deferred.
4. Explain to the patient and to the surgeon's office why the test was deferred, and state that the referral will be honored once he is cleared.

Absolute versus relative: acute MI within one month, unstable angina, and unstable arrhythmia are conventionally treated as absolute for the moment; recent thoracic/abdominal/eye surgery, pregnancy, and aneurysms are relative. The distinction matters because relative contraindications can be overridden by a documented risk-benefit discussion - an acute coronary syndrome cannot. "The surgeon needs the numbers" is a scheduling pressure, not a clinical justification; the harm of provoking an event in the laboratory far outweighs a one-day delay.

Preparation

• Confirm and document the written clearance and his current medications; check whether he is anticoagulated (relevant to epistaxis/hemoptysis risk with forced maneuvers, though not a contraindication).
• Recheck sitting vitals and SpO2 before starting; record the baseline so any fall is interpretable.
• Confirm he can tolerate the nose clip and mouthpiece and understands the maneuver, because the dizziness is most likely a Valsalva/straining response rather than disease.

Modify the technique, not the test

• Seated, upright, feet flat, chair with arms; never standing. Have him hold the chair, not his breath, between efforts.
• Limit the number of efforts and add a 1-2 minute rest between them; the target is 3 acceptable efforts, not the full 8.
• Coach the open-glottis technique: blow out, do not "hold and push." A breath-hold against a closed glottis is what produces presyncope.
• Monitor SpO2 during and after each effort; stop if SpO2 falls below the laboratory's threshold (typically a drop of >4% or to <88%) or if he becomes symptomatic.
• Have him sit quietly for several minutes after the last effort rather than walking straight out; syncope in this population typically occurs 30-60 seconds after the maneuver.
• Keep oxygen and a crash cart/emergency plan in reach; know the code route for this laboratory.

The albuterol and tiotropium are not a reason to postpone routine spirometry - ATS/ERS guidance is that bronchodilators are not withheld before routine diagnostic spirometry; they are only withheld when the specific question is bronchodilator responsiveness or bronchial challenge. Document the time of the last dose so the bronchodilator status of the result is unambiguous.

Both would change the plan substantially.

Albuterol 20 minutes ago

• A beta-2 agonist produces near-maximal bronchodilation within 15-30 minutes. Challenging now would antagonize the methacholine and produce a falsely negative (or falsely "non-responsive") result.
• Short-acting beta agonists are conventionally withheld for at least 8 hours (long-acting agents much longer; follow the laboratory's written withhold table and confirm with the ordering provider). Other agents with the same effect - ipratropium, leukotriene modifiers, antihistamines, and caffeine-containing food/drink - also need to be screened against the protocol.
• The practical answer: reschedule and re-educate, not "test anyway and note it."

SpO2 94% on room air

• A challenge deliberately induces bronchoconstriction. In a patient with limited gas-exchange reserve, the risk of a clinically significant desaturation during the provocation is real, and the test loses interpretability if it must be aborted mid-series.
• Baseline spirometry is required first. A methacholine challenge is generally not offered when baseline FEV1 is markedly reduced (commonly <60-70% predicted or below about 1.0-1.5 L depending on the protocol); if his baseline FEV1 is that low, the challenge is the wrong test and the question should be answered another way.
• Confirm that the patient is not on supplemental oxygen, because the delivery device and the airflow will interfere with the nebulizer dosing and with the SpO2 interpretation.

Bottom line: for the methacholine order, the correct response is to hold the test, screen the medication list against the withhold table, verify baseline spirometry, and document why the visit became an education and scheduling encounter.